Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 19,436 | 5,835 | 13,911 | 18,114 | 21,219 |
| Cost of Goods | 4,578 | 2,170 | 3,604 | 3,929 | 5,731 |
| Gross Profit | 14,858 | 3,665 | 10,307 | 14,185 | 15,488 |
| Operating Expenses | 15,161 | 13,669 | 17,494 | 17,029 | 16,097 |
| Operating Income | 275 | -9,834 | -6,583 | -1,915 | 122 |
| Other Income | -217 | -6 | 1,582 | -892 | 1,447 |
| Pre-tax Income | 58 | -9,840 | -5,001 | -2,807 | 1,569 |
| Income Tax | 157 | -136 | 209 | -1,187 | 383 |
| Net Income Continuous | -99 | -9,704 | -5,210 | -1,620 | 1,186 |
| Net Income Discontinuous | -50 | 19 | -817 | N/A | -469 |
| Net Income | $-149 | $-9,685 | $-6,027 | $-1,620 | $717 |
| EPS Basic Total Ops | -0.01 | -0.37 | -0.23 | -0.06 | 0.03 |
| EPS Basic Continuous Ops | 0.00 | -0.37 | -0.20 | -0.05 | 0.04 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | -0.03 | N/A | -0.02 |
| EPS Diluted Total Ops | -0.01 | -0.37 | -0.23 | -0.06 | 0.03 |
| EPS Diluted Continuous Ops | 0.00 | -0.37 | -0.20 | -0.05 | 0.04 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | -0.03 | N/A | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.37 | -0.20 | -0.06 | 0.04 |
| EBITDA(a) | $789 | $-9,374 | $-6,117 | $-1,366 | $526 |